Target intelligence / Profile preview

Kelch repeat and BTB domain-containing protein 6 (KBTBD6)

Target
KBTBD6
Molecular classification
Substrate adaptor protein, Component of E3 ubiquitin ligase complex, Scaffold/adaptor protein, Other
01

Overview

Kelch repeat and BTB domain-containing protein 6 (KBTBD6) is a cytoplasmic and nuclear protein, encoded on human chromosome 13q14.11, that functions as a substrate-specific adaptor for the Cullin-3 RING-type E3 ubiquitin ligase complex (CUL3)[1][5]. KBTBD6 operates primarily as part of the CUL3(KBTBD6/7) E3 ubiquitin ligase complex, recruiting the guanine exchange factor TIAM1 for RAC1 and mediating its Lys-48–linked ubiquitination and subsequent proteasomal degradation[2][4][3]. Regulation of TIAM1 abundance by KBTBD6 controls RAC1 GTPase signaling, affecting actin cytoskeleton organization, cell migration, and proliferation. KBTBD6 possesses an ATG8 interaction motif (AIM) for interactions with GABARAP, and Kelch repeats for binding TIAM1; the BTB domain enables interaction with CUL3[3][4]. No direct links to therapeutic drugs, well-validated disease biomarkers, or major safety concerns have been established for KBTBD6 in the current literature.

Other names
Kelch repeat and BTB domain-containing protein 6KBTBD6DKFZp547E1912kelch repeat and BTB (POZ) domain containing 6
02

Biological functions

Ubiquitin-dependent protein catabolic processProtein ubiquitination (specifically Lys-48–linked ubiquitination)Regulation of Rac protein signal transductionRegulation of actin cytoskeleton organizationCell migrationCell proliferation
03

Disease associations

Other(No established role in common diseases such as cancer, inflammation, neurodegeneration, etc., based on current sources)

Beyond the preview

Go deeper on Kelch repeat and BTB domain-containing protein 6 (KBTBD6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kelch repeat and BTB domain-containing protein 6 (KBTBD6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call